Squarepoint Ops LLC Enanta Pharmaceuticals Inc Transaction History

Squarepoint Ops LLC

$62.8 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$8.18 - $10.78 $870,376 - $1.15 Million	106,403 New	106,403 $1 Million
Q1 2023 May 15, 2023	SELL	$38.82 - $54.59 $166,343 - $233,918	-4,285 Reduced 31.01%	9,533 $385,000
Q4 2022 Feb 14, 2023	BUY	$40.77 - $53.73 $350,825 - $462,346	8,605 Added 165.07%	13,818 $642,000
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $251,735 - $371,530	5,213 New	5,213 $270,000
Q3 2021 Nov 15, 2021	SELL	$41.02 - $58.65 $201,982 - $288,792	-4,924 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $215,474 - $261,513	4,924 New	4,924 $217,000
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $216,954 - $250,214	-5,271 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$43.36 - $53.53 $54,893 - $67,768	-1,266 Reduced 19.37%	5,271 $241,000
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $698,981 - $867,960	-15,074 Reduced 69.75%	6,537 $328,000
Q1 2020 May 15, 2020	BUY	$40.22 - $62.0 $389,088 - $599,788	9,674 Added 81.04%	21,611 $1.11 Million
Q4 2019 Feb 14, 2020	SELL	$57.95 - $66.61 $1.31 Million - $1.5 Million	-22,561 Reduced 65.4%	11,937 $737,000
Q3 2019 Nov 14, 2019	BUY	$60.08 - $88.17 $1.64 Million - $2.41 Million	27,303 Added 379.47%	34,498 $2.07 Million
Q2 2019 Aug 14, 2019	SELL	$81.3 - $97.35 $260,891 - $312,396	-3,209 Reduced 30.84%	7,195 $607,000
Q1 2019 May 15, 2019	SELL	$69.08 - $105.66 $821,153 - $1.26 Million	-11,887 Reduced 53.33%	10,404 $994,000
Q4 2018 Feb 14, 2019	BUY	$65.41 - $84.65 $784,069 - $1.01 Million	11,987 Added 116.33%	22,291 $1.58 Million
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $656,845 - $971,279	-7,686 Reduced 42.72%	10,304 $881,000
Q2 2018 Aug 14, 2018	SELL	$81.85 - $120.51 $506,405 - $745,595	-6,187 Reduced 25.59%	17,990 $2.09 Million
Q1 2018 May 15, 2018	SELL	$57.91 - $92.15 $132,555 - $210,931	-2,289 Reduced 8.65%	24,177 $1.96 Million
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $1.21 Million - $1.57 Million	26,466	26,466 $1.55 Million

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$19.7 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$18.5 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$17.3 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$14 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$10.3 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Account